In 42 patients about to undergo cardiac surgery, anaesthesia was induced with either Althesin or thiopentone. Arterial pressure, central venous pressure, pulse rate and the electrocardiogram were monitored in all patients. Cardiac output was measured in 16 patients. Althesin produced a smooth induction of anaesthesia and was indistinguishable clinically from thiopentone in this respect. The cardiovascular effects of the two drugs were similar, a reduction of both arterial pressure and cardiac output being noted, associated with decreases in stroke volume. The heart rate and calculated systemic vascular resistance were unchanged. Laryngoscopy and endotracheal intubation caused an increase in both heart rate and arterial pressure. The mean induction dose of Althesin was 27.7 /"I/kg, compared with 2.5 mg/kg of thiopentone. and methohexitone, whilst Campbell et al. (1971) , in a study of 6 patients undergoing cardiac catheterization, found a much smaller decrease in arterial pressure, together with an increase in heart rate. In these patients the cardiac output, measured at 2 min after injection, was well maintained despite a dose of 100 ^1/kg given over 15 sec. It was considered that Althesin had probable advantages over other induction agents in such patients.
In 42 patients about to undergo cardiac surgery, anaesthesia was induced with either Althesin or thiopentone. Arterial pressure, central venous pressure, pulse rate and the electrocardiogram were monitored in all patients. Cardiac output was measured in 16 patients. Althesin produced a smooth induction of anaesthesia and was indistinguishable clinically from thiopentone in this respect. The cardiovascular effects of the two drugs were similar, a reduction of both arterial pressure and cardiac output being noted, associated with decreases in stroke volume. The heart rate and calculated systemic vascular resistance were unchanged. Laryngoscopy and endotracheal intubation caused an increase in both heart rate and arterial pressure. The mean induction dose of Althesin was 27.7 /"I/kg, compared with 2.5 mg/kg of thiopentone. and methohexitone, whilst Campbell et al. (1971) , in a study of 6 patients undergoing cardiac catheterization, found a much smaller decrease in arterial pressure, together with an increase in heart rate. In these patients the cardiac output, measured at 2 min after injection, was well maintained despite a dose of 100 ^1/kg given over 15 sec. It was considered that Althesin had probable advantages over other induction agents in such patients.
The present study was designed to investigate the minimum dose of Althesin required as an induction agent for cardiac surgical patients and the comparable dose of thiopentone. In addition the effects of both drugs on cardiac output, arterial pressure, heart rate and central venous pressure have been compared.
PATIENTS AND METHODS
Informed consent was obtained from all patients before operation. Twenty-three patients were given Althesin and 19 received thiopentone. Cardiac output measurements were made in 6 and 10 patients from each group respectively (table I) .
All patients were given papaveretum and hyoscine by intramuscular injection 1 hour before operation. The respective doses were 20 mg and 0.4 mg, where the patient weighed more than 70 kg, 15 mg and 0.3 mg, where the weight was between 60 and 70 kg, and 10 mg and 0.2 mg for weights less than 60 kg. All patients arrived at the theatre calm and sedated and some were asleep.
The two main requirements of any anaesthetic induction agent are a smooth, pleasant onset of unconsciousness together with minimal depressant effects on the cardiorespiratory systems. These requirements are of particular importance in patients with cardiac disease.
The new steroid anaesthetic agent Althesin produces a rapid induction of anaesthesia with a high therapeutic index in animals (Child et al., 1971) , and studies in healthy patients have shown relatively minor cardiovascular changes at optimal dose levels (Campbell et al., 1971; Clarke et al., 1971) . Further work by Savage et al. (1972) , in fit patients, demonstrated that the effects observed were similar to those produced by the intravenous barbiturates.
However, conflicting results have been described following the administration of Althesin to patients with cardiac disease. In five patients with cardiac pathology Harrison and Sellick (1972) found a profound reduction in mean arterial pressure of over 40% associated with a tachycardia following the administration of Althesin (mean dose 50 /*l/kg, injected over 30 sec). They concluded that, in view of the hypotensive effect of the drug, they could not continue to use Althesin in such patients until they could measure cardiac output. Lyons and Clarke (1972) , also using Althesin 50 /*l/kg over 30 sec, found a smaller decrease in arterial pressure and a tachycardia similar to that produced by thiopentone Before the induction of anaesthesia, a central venous catheter was inserted and a 20-gauge Argyle "Medicut" was placed in the radial artery after infiltration of the overlying skin with local anaesthetic. The arterial and central venous pressures were recorded using Bell & Howell pressure transducers attached to a Devices 4-channel recorder. An electrocardiogram was recorded also and the heart rate was measured by counting the e.c.g. complexes over 1-min periods.
When measurements of heart rate and arterial pressure were steady, the induction of anaesthesia was commenced using a minimal dose technique, so that a comparable weight-related dose could be determined for each drug. The total amount of induction agent used was assessed clinically; depth of anaesthesia being considered adequate when the eyelash reflex was abolished, there was no movement to stimulation of the ear and the pupils did not react to light. Incremental doses of either Althesin or thiopentone were given intravenously over 10-sec periods. To allow the accurate administration of small doses and to provide a similar volume of fluid to the thiopentone used, the Althesin was diluted with saline to give a concentration of 3 mg/ml of steroid. The dosage used in the induction technique for both drugs was:
Althesin Thiopentone Minute 1 750/4 (9 mg) 50 mg Minute 2 500/4 (6 mg) 25 mg Minute 3 500/4 (6 mg) 25 mg These increments were continued until the ear-nip response was negative. Cardiac output was measured using the dye dilution technique with indocyanine green. The dye was detected using a Gilford densitometer and the output curve inscribed using a Smith's "Servoscribe" recorder. Cardiac output was determined on two occasions prior to the induction of anaesthesia (the mean values are presented in table IV). A third measurement of cardiac output was made at the end of the period of induction. Thereafter suxamethonium (100 mg) was given to facilitate endotracheal intubation.
RESULTS
Althesin was indistinguishable clinically from thiopentone as an induction agent. In several patients the incremental dose of Althesin or thiopentone was doubled at the third minute to speed the onset of loss of consciousness. The mean induction dose of Althesin was 27.7 /4/kg (SD 9.09; range 15.2 to 52.8 /4/kg). For thiopentone the mean dose was 2.5 mg/kg (SD 1.09; range 1.3 to 4.4 mg/kg). The times of negative ear-nip response and minimal arterial pressure are shown in table VI.
There was no significant change in heart rate during induction with either agent (table II) . However, significant decreases in arterial pressure were observed following the injection of both Althesin and thiopentone (table III) . In addition there was a significant decrease in cardiac output during induction, when using Althesin (table IV) , whereas with thiopentone the decrease in cardiac output was not significant (table V) . A decrease in stroke volume and an increase in mean systemic vascular resistance were noted to occur with both drugs, but these changes were not statistically significant (tables IV and V).
Systemic vascular resistance was calculated as follows: The mean heart rate was obtained by summing the e.c.g. complexes over 1 min. Gray and Riding (1957) suggested that the safest method for the induction of anaesthesia, in the poorly compensated cardiac patient, was an inhalational induction with nitrous oxide and oxygen. Similarly, induction with cyclopropane and oxygen is widely used, as is halothane, nitrous oxide and oxygen (Moffitt, Tarham and Lundberg, 1968) . In a more recent review by Gilston (1971) an intravenous method of induction with small doses of thiopentone given slowly, followed by suxamethonium for muscle relaxation and intubation, was advocated. Nonetheless thiopentone has disadvantages due to its direct myocardial depressant action (Price and Helrich, 1955) .
From the results of this trial, Althesin would seem to be a potent and reliable induction agent for use in patients with severe myocardial and valvular, disease. The incidence of unwanted side effects was low. Extraneous muscle movements (Campbell et al., 1971) were not seen and there was no incidence of a skin flush . The relatively slow induction of anaesthesia did not distress any patient. There was a progressive loss of consciousness and it could usually be predicted which dose of drug would lead to the loss of the eyelash reflex. In a few cases further increments were required after the loss of consciousness in order to obtain a negative ear-nip response, this latter test being considered the best method of assessing the depth of anaesthesia. The incidence of apnoea after the loss of the lash reflex was greater in the Althesin patients.
The dose of Althesin recommended for the induction of anaesthesia varies widely from 30 /"I/kg (Miller, Bradford and Campbell, 1972) to 150 //I/kg (Campbell et al., 1971) . However, the most commonly used dose appears to be between 50 and 60 /<l/kg (Clarke et al., 1971; Savege et al., 1972) . Our mean induction dose for Althesin was 27.7 j"l/kg, each increment being given over 10 sec with pauses of 1 min between (Gilston, 1971 ). This dose is approximately half of that used by other workers, but consistent decreases in cardiac output and arterial pressure were still observed. In this study the mean induction dose for thiopentone was 2.5 mg/kg, and thus gives a potency ratio of Althesin to thiopentone (/xl/kg: mg/kg) of 1:10.8. This ratio is in broad agreement with that noted by Tammisto et al. (1972) and Clarke, Dundee and Carson (1972) .
Our patients were extremely sensitive to any degree of respiratory obstruction, even when this was difficult to detect clinically, although changes in the central venous pressure and arterial pressure with respiration could be observed. In addition, associated with the respiratory obstruction, there was an immediate onset of cardiac arrhythmias due either to nodal rhythm or to occasional ventricular ectopic beats. These disappeared as soon as the obstruction was relieved. Similar arrhythmias were present in a few patients during laryngoscopy (PrysRoberts et al., 1971) .
No significant changes in heart rate occurred during induction, but significant increases were present in both groups during laryngoscopy and intubation. This differs from the results of Savege et al. (1972) , Campbell et al. (1971) and PrysRoberts et al. (1971) , who observed an increase in heart rate following Althesin. However, it should be noted that the patients in these studies received no premedication. Our findings agree with those of Lyons and Clarke (1972) who studied the effect of Althesin on patients who had received a narcotic premedication. The similarity of induction time for both Althesin and thiopentone groups is in agreement with Tammisto et al. (1972) . However, there was a significant difference in the time of the maximum fall in arterial pressure (table VI) .
Both agents caused a reduction in cardiac output. This was significant for Althesin (P<0.02) but not so for thiopentone. The stroke volume decreased in every patient, but the mean systemic vascular resistance was changed little by either drug. These observations differ from those of Campbell et al. (1971) , who found a decrease in systemic vascular resistance with Althesin, and those of Flickinger et al. (1961) , who found an increase using thiopentone.
As there was no significant change in heart rate, the decrease in cardiac output in both groups of patients can be attributed to a reduction in stroke volume. In previous studies of Althesin, Savege et al. (1972) attributed the maintenance of cardiac output to a rise in heart rate, and they and Campbell et al. (1971) found significant increases in heart rate in younger fit patients in whom cardiac output was unchanged. Miller, Bradford and Campbell (1972) suggested that patients with conduction defects or heart block may be unable to increase their heart rate with a consequent decrease in cardiac output and systemic arterial pressure.
An increase in arterial pressure and heart rate in association with laryngoscopy has been reported previously (Forbes and Dally, 1970; Takki et al., 1972) . It is interesting that these patients, all with severe cardiac pathology, could produce such a rapid and large change in pulse rate and arterial pressure, the latter being due to increased cardiac output rather than an increased systemic vascular resistance (Prys-Roberts et al., 1971) .
It is concluded that Althesin can be used satisfactorily as an induction agent for poorly compensated myocardial and valvular diseased patients when used in small increments slowly, but does produce a more pronounced fall in cardiac output than thiopentone, over which it offers no special advantage.
